SCHEMBL7141622

SCHEMBL7141622

CCC(C)(C(=O)O)C1CCN(C(=O)OC(C)(C)C)CC1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.49
GPR119 Q8TDV5 5/20 0.47
RECQL P46063 1/20 0.47
EPHX1 P07099 1/20 0.47
KDM4E B2RXH2 2/20 0.45
PKM P14618 1/20 0.45
USP2 O75604 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
MAPT P10636 2/20 0.43
THRB P10828 1/20 0.43
PTPN2 P17706 1/20 0.43
PTPN1 P18031 1/20 0.43
PTPN6 P29350 1/20 0.43
DPP4 P27487 1/20 0.43
STS P08842 1/20 0.43
MEN1 O00255 1/20 0.42
ALDH1A1 P00352 1/20 0.42
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21970972 0.83 HPGD (0.53) HPGDGPR119RECQLEPHX1KDM4E
SCHEMBL2394908 0.81 HPGD (0.54) HPGDGPR119RECQLEPHX1KDM4E
SCHEMBL6152125 0.80 HPGD (0.50) HPGDGPR119RECQLEPHX1KDM4E
SCHEMBL24170528 0.80 HPGD (0.50) HPGDGPR119RECQLEPHX1KDM4E
SCHEMBL408862 0.79 HPGD (0.58) HPGDGPR119RECQLEPHX1KDM4E
SCHEMBL22648878 0.78 HPGD (0.51) HPGDGPR119RECQLEPHX1KDM4E
SCHEMBL25173198 0.78 HPGD (0.51) HPGDGPR119RECQLEPHX1KDM4E
SCHEMBL21783713 0.78 HPGD (0.48) HPGDGPR119RECQLEPHX1KDM4E
SCHEMBL32671892 0.77 HPGD (0.57) HPGDGPR119RECQLEPHX1KDM4E
SCHEMBL21579340 0.77 HPGD (0.47) HPGDGPR119RECQLEPHX1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6518423-B1 These compounds are useful as drugs efficacious in the prevention and treatment of these various inflammatory diseases and immunologic diseases, such as rheumatoid arthritis, atopic dermatitis, psoriasis, asthma, and EISAI CO., LTD. (JP) 2003-02-11 US disclosed